Clinical Evaluation of the Safety and Performance of FRF for the Treatment and Reduction of Acne Scarring
Clinical Evaluation of the Safety and Performance of Fractional Radiofrequency for the Treatment and Reduction of Acne Scarring
Sponsor: Venus Concept
Listed as NCT04827680, this NA trial focuses on Acne Scars - Mixed Atrophic and Hypertrophic and remains completed. Sponsored by Venus Concept, it has been updated 9 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Nov 2023 — Jul 2024 [monthly]
Completed NA
-
Jul 2023 — Nov 2023 [monthly]
Completed NA
-
May 2023 — Jul 2023 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
▶ Show 4 earlier versions
-
Jun 2022 — May 2023 [monthly]
Active Not Recruiting NA
Status: Enrolling By Invitation → Active Not Recruiting
-
Nov 2021 — Jun 2022 [monthly]
Enrolling By Invitation NA
-
Jun 2021 — Nov 2021 [monthly]
Enrolling By Invitation NA
-
May 2021 — Jun 2021 [monthly]
Enrolling By Invitation NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Venus Concept
For direct contact, visit the study record on ClinicalTrials.gov .